2nd Annual

Bioprocessing Venture, Innovation & Partnering

Innovation & Investment for Manufacturing Biologics and Advanced Therapeutics

August 21, 2024


The 2nd Annual Bioprocessing Venture, Innovation & Partnering Conference will bring together leading investors, innovators, manufacturers, and suppliers who are driving the future of bioprocessing.

This partnering conference aims to bring together C-level executives from investment firms, biopharmaceutical manufacturers, CDMOs, equipment suppliers, and innovative startups to discuss the most timely and important issues facing innovation in bioprocessing. We will include strategies from big and small pharma, venture, and corporate arms who have a vested interest in driving this innovation, plus CEOs and innovators from across the biologic, cell, and gene therapy space.

This unique combination offers the opportunity to participate in a venture and partnering event featuring a very exciting and emerging space, while also offering the chance to visit the Exhibit Hall and meet companies and get a sense of where this industry is going.

Coverage will include, but is not limited to:

  • Investment Trends in Advanced Therapeutics Modalities
  • Accelerating Bioprocessing Innovation and Technology
  • CDMO & Services & Tools
  • Next-Generation Bioprocessing Technologies
  • Investment Trends and Opportunities in Bioprocessing
  • Collaboration and Partnerships
  • Supply Chain Resilience and Sustainability
  • M&A and Strategic
  • Investor Panel
  • Supply Chain for CGT
  • CEO Panel

Co-Chairs

Daniella Kranjac, Founding General Partner, Avant Bio LLC

Ran Zheng, CEO, Landmark Bio

Ann Lee, CTO, Prime Medicine

Featured Speakers/Companies from Last Year's Event

Valerie Dixon, Managing Director, Morgan Stanley

Emmanuel Ligner, President and CEO, Cytiva

John Ho, Partner, Anzu Partners

Hari Pujar, Operating Partner, Flagship Pioneering; COO, Tessera Therapeutics

Murali Venkatesan, Head, Danaher Ventures, Americas & Europe; Vice President, Science, Technology & Innovation, Danaher Corporations

Heather Erickson, Vice President, Supply Chain Management & Business Operations, Sangamo

Daniella Cramp, Senior Vice President and President, Bioproduction Group, Thermo Fisher Scientific

Ulrike Lemke, Business Unit President, Sterile Fill & Finish, Recipharm AG

Who Should Attend

INVESTMENT FIRMS:

  • VC/PE/CVC Investors & Angels
  • Senior Investors (Managing Partners/Directors & General Partners)
  • Investors (Partners, Investors & Principals)
  • Portfolio Advisors (Venture & Operating Partners)

STARTUPS and GROWTH COMPANIES:

  • Emerging Company Leaders
  • Founders & CEOs
  • C-Suite Executives (CSOs, CIOs, CTOs, etc.)
  • Innovation & Strategy Managers (Senior Vice Presidents, Vice Presidents & Directors)

CORPORATIONS:

  • Manufacturing, CDMO & Supplier Executives
  • Business Development Heads (Senior Vice Presidents, Vice Presidents & Directors)
  • Innovation & Strategy Managers (Senior Vice Presidents, Vice Presidents & Directors)
  • Venture Leaders (Managing Directors, Partners & Directors)

Key Contacts

CONFERENCE CONTENT
Nandini Kashyap, MPharm.
Senior Director, Conferences
(+1) 781-972-5406
nkashyap@healthtech.com
LinkedIn profile

PARTNERING & SPONSORSHIP
Brian Caine
Specialized Business Development Manager
(+1) 908-809-0946
bcaine@healthtech.com
LinkedIn profile